论文部分内容阅读
[目的]观察气滞胃痛颗粒联合莫沙必利治疗糖尿病胃轻瘫疗效。[方法]使用随机平行对照方法,将62例门诊患者按就诊顺序简单随机分为两组。对照组31例莫沙必利,10mg/次,3次/d,进食前0.5h口服。治疗组31例气滞胃痛颗粒,5g/次,3次/d;莫沙必利治疗同对照组。连续治疗4周为1疗程。观测临床症状、胃排空率、不良反应。治疗1疗程,判定疗效。[结果]治疗组治愈19例,显效4例,有效6例,无效2例,总有效率93.50%。对照组治愈10例,显效5例,有效5例,无效11例,总有效率64.52%。治疗组疗效优于对照组(P<0.05)。临床症状积分及胃排空率改善治疗组优于对照组(P<0.05)[结论]气滞胃痛颗粒联合莫沙必利治疗糖尿病胃轻瘫效果显著,值得推广。
[Objective] To observe the curative effect of qi stagnation stomach granule combined with mosapride on diabetic gastroparesis. [Methods] Using randomized parallel control method, 62 outpatients were randomly divided into two groups according to the order of visiting doctor. Control group, 31 cases of mosapride, 10mg / time, 3 times / d, oral 0.5h before eating. The treatment group, 31 cases Qi stagnation stomach pain particles, 5g / times, 3 times / d; mosapride treatment with the control group. Continuous treatment for 4 weeks for a course of treatment. Observation of clinical symptoms, gastric emptying rate, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Result] In the treatment group, 19 cases were cured, 4 cases were markedly effective, 6 cases were effective, 2 cases were ineffective and the total effective rate was 93.50%. The control group was cured in 10 cases, markedly effective in 5 cases, effective in 5 cases, ineffective in 11 cases, the total effective rate was 64.52%. The treatment group was better than the control group (P <0.05). Clinical symptom scores and gastric emptying rate were improved in the treatment group than in the control group (P <0.05) [Conclusion] The combination of qi stagnation and stomach pain granules combined with mosapride treatment of diabetic gastroparesis significant effect, worthy of promotion.